Analysts have clear opinions on GMED.

There are 10 analysts on the Wall offering 12 month price targets for Globus Medical in the last 3 months. The average price target is $63.56 with a high forecast of $67.00 and a low forecast of $60.00. The average price target represents a 20.24% increase from the last price of $52.86.
Globus Medical, Inc. (GMED) is followed by 10 analysts on the street.

Richard Newitter from Leerink Partners rates it a Buy with a target of $63.00.

Similarly, 6 days ago Craig Bijou of Cantor Fitzgerald Reiterated a Buy with a target of $64.00.

The consensus on the street is Strong Buy.

What does Globus Medical, Inc.(GMED) do ?
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul in March 2003 and is headquartered in Audubon, PA.

Globus Medical, Inc. (GMED) Insider Trades

Multiple company employees have indulged in significant insider trading. Globus Medical, Inc. disclosed the following in a document filed with the US Securities and Exchange Commission (SEC):

SVP, GC, Huller Kelly : S – Sale+OE(-$380,494) of GMED in the trading session of 2019-12-17.

Dir Davidar David D : S – Sale(-$2,592,400) of GMED in the trading session of 2019-11-07.

SVP, GC Huller Kelly : S – Sale(-$167,700) of Globus Medical, Inc. in the trading session of 2019-11-07.

Looking for stocks just like GMED?

Based on Wall Street analyst research, several stocks are similar to GMED
They are:
– ATEC [Info can be found here: ]
– ZBH [Info can be found here: ]
– OFIX [Info can be found here: ]